Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study

The programmed death receptor 1 (PD1) and its ligand programmed death receptor ligand 1 (PDL1) are the most widely used immune checkpoints in cancer immunotherapy. The related literature shows the explosive growth trends due to the promising outcomes of tumor regression. The present study aimed to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yiting, Jiang, Liqing, Wen, Ti, Guo, Xiaoyu, Shao, Xinye, Qu, Hui, Chen, Xi, Song, Yujia, Wang, Fang, Qu, Xiujuan, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418110/
https://www.ncbi.nlm.nih.gov/pubmed/34489691
http://dx.doi.org/10.3389/fphar.2021.670900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418110/
https://www.ncbi.nlm.nih.gov/pubmed/34489691
http://dx.doi.org/10.3389/fphar.2021.670900

Ejemplares similares